Table 1.
Baseline demographic and clinicopathologic characteristics of the patients.
| Characteristic | Patients (n = 306) |
|---|---|
| Age, years | 71 [62, 79] |
| Year of diagnosis | |
| 2000–2005 | 61 (19.9) |
| 2006–2010 | 96 (31.4) |
| 2011–2016 | 149 (48.7) |
| Sex | |
| Male | 170 (55.6) |
| Female | 136 (44.4) |
| Race | |
| Caucasian | 254 (83.0) |
| African | 35 (11.4) |
| Other | 17 (5.6) |
| Tumor site | |
| Renal pelvis | 221 (72.2) |
| Ureter | 85 (27.8) |
| Laterality | |
| Left | 138 (45.1) |
| Right | 168 (54.9) |
| Tumor size | |
| <2 cm | 22 (7.2%) |
| ≥2 cm | 284 (92.8%) |
| T stage | |
| T2 | 44 (14.4) |
| T3 | 153 (50.0) |
| T4 | 109 (35.6) |
| Pathological grade | |
| Low grade | 28 (4.5) |
| High grade | 278 (95.5) |
| RLNs | 8 [6, 14] |
| pLNs | 3 [1, 5] |
| pLND, % | 33.3 [16.9, 66.7] |
| Adjuvant radiotherapy | |
| Yes | 23 (7.5) |
| No | 283 (92.5) |
| Adjuvant chemotherapy | |
| Yes | 161 (52.5) |
| No | 145 (47.5) |
| Follow-up, months | 16.5 [8, 29] |
Data are presented as n (%) or median [IQR]. RLNs, removed lymph nodes; pLNs, positive lymph nodes; pLND, positive lymph node density; IQR, interquartile range.